Shares of Seagen Inc. (NASDAQ:SGEN – Get Free Report) have been assigned an average rating of “Hold” from the seventeen brokerages that are presently covering the firm, MarketBeat Ratings reports. Eleven research analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month price […]
StockNews.com assumed coverage on shares of Seagen (NASDAQ:SGEN – Free Report) in a research report sent to investors on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. A number of other brokerages also recently commented on SGEN. TheStreet downgraded Seagen from a c- rating to a d+ rating in a […]
Alta Advisers Ltd purchased a new position in Seagen Inc. (NASDAQ:SGEN – Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 300 shares of the biotechnology company’s stock, valued at approximately $64,000. A number of other institutional investors have also recently made […]
Alta Advisers Ltd purchased a new position in shares of Seagen Inc. (NASDAQ:SGEN – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 300 shares of the biotechnology company’s stock, valued at approximately $64,000. Several other hedge funds also recently modified their holdings […]
Sumitomo Mitsui DS Asset Management Company Ltd reduced its stake in shares of Seagen Inc. (NASDAQ:SGEN – Free Report) by 0.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,633 shares of the biotechnology company’s stock after selling […]